Jade Biosciences, Inc. (JBIO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $14.56
• Market Cap: $715.06M
• 52-Week High: $97.54
• 52-Week Low: $6.57

About Jade Biosciences, Inc.

Jade Biosciences, Inc. is a biotechnology company headquartered in Waltham, Massachusetts, specializing in the development of innovative therapies for inflammatory and immunological disorders, particularly autoimmune diseases. The firm is committed to addressing significant unmet medical needs through its proprietary drug development pipeline, which is underpinned by advanced research and scientific rigor. With a focus on transforming patient care in the realm of immunotherapy, Jade Bioscienc...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Jade Biosciences, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does JBIO pay dividends?

Jade Biosciences, Inc. (JBIO) does not currently pay a regular dividend.

What is JBIO's market cap?

Jade Biosciences, Inc. (JBIO) has a market capitalization of $715.06M with a current stock price of $14.56.